Certification:
ISO 9001:2015
Model Number:
ART202S
Meta Description: Anrate ART202S is GMP-grade recombinant human holo transferrin for industrial biomanufacturing and serum-free cell culture. 100% animal-origin-free, ≥98.0% purity, low endotoxin, scalable supply for CHO cell culture, CGT and biopharmaceutical production.
Anrate ART202S recombinant human holo transferrin is a high-purity, fully iron-saturated transferrin manufactured under GMP-compliant conditions, purpose-built for industrial-scale cell culture and biologic production. Expressed in a Pichia pastoris expression system with a completely animal-free production chain, it delivers stable, receptor-mediated iron transport performance while eliminating contamination risks associated with plasma-derived transferrin, making it the ideal raw material for chemically defined, serum-free media formulations in commercial biomanufacturing.
ART202S holo transferrin is validated across mainstream industrial bioproduction workflows:
Manufactured with fully animal-free raw materials and closed production processes, ART202S eliminates risks of TSE/BSE, viral and mycoplasma contamination inherent to serum-sourced transferrin. It aligns with FDA, EMA and NMPA requirements for xeno-free biopharmaceutical production, simplifying regulatory filing and audit trails.
Produced in our ISO 9001-certified, GMP-compliant production facility, every batch of ART202S follows standardized fermentation and purification processes. With single-batch production capacity reaching the hundred-kilogram scale, we guarantee minimal batch-to-batch variation and stable product performance across long-term production campaigns.
From gram-level process development to multi-kilogram commercial manufacturing, Anrate offers flexible packaging and bulk supply solutions. Our vertically integrated production chain ensures stable lead times and reliable long-term supply security to support seamless scale-up from R&D to commercial production.
WhatsApp: +85363312841 | Email: sales@bjanrate.cn
Send your inquiry directly to us